Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-15 Purchase |
2021-06-17 7:09 pm |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
11,764 | $8.5 | $99,994 | 20,764 (Direct) |
View |
| 2021-06-03 Sale |
2021-06-04 7:52 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
9,492 | $21.96 | $208,421 | 122,196 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-02 9:47 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,119 | $22.1 | $996,963 | 131,688 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-07 6:28 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
20,416 | $23.45 | $478,845 | 149,034 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 8:04 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,000 | $24.08 | $1,083,718 | 249,866 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-24 Option Award |
2024-06-25 4:05 pm |
N/A 2034-06-24 |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:19 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
55,000 | $0 | 98,750 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-17 5:28 pm |
N/A 2033-07-14 |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
55,000 | $0 | 73,750 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-29 4:15 pm |
N/A 2032-06-28 |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
41,250 | $0 | 41,250 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,518 | $0 | 160,214 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-17 4:22 pm |
N/A 2031-12-16 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-03-11 Gift |
2021-11-22 4:03 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
7,500 | $0 | 114,696 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 7:09 pm |
N/A 2031-06-17 |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
9,000 | $0 | 20,764 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 9:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
33,189 | $0 | 131,688 (Direct) |
View |
| 2021-05-06 Exercise |
2021-05-07 6:28 pm |
N/A 2025-08-31 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
20,416 | $0 | 149,034 (Direct) |
View |
| 2021-05-06 Exercise |
2021-05-07 6:28 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
20,416 | $10.66 | 149,034 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 8:04 pm |
N/A 2025-08-31 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,000 | $0 | 249,866 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 8:04 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,000 | $10.66 | 249,866 (Direct) |
View |
| 2021-03-02 Tax Withholding |
2021-03-03 8:39 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,906 | $23.25 | 325,782 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 8:39 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
23,812 | $0 | 325,782 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 8:39 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
4,934 | $24.06 | 325,782 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:39 pm |
N/A 2031-02-28 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
127,900 | $0 | 325,782 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:26 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,875 | $0 | 130,521 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 5:26 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,318 | $21.35 | 130,521 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-17 5:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
498 | $4.59 | 124,089 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 5:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,734 | $0 | 124,089 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-25 6:38 pm |
N/A 2030-06-23 |
PDS Biotechnology Corp | PDSB | Ali-Jackson Kamil Director |
3,033 | $0 | 3,033 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:42 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
9,534 | $1.32 | 156,042 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:42 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
33,188 | $0 | 156,042 (Direct) |
View |